Tomokazu Souma
- Nephrology top 2%
- Clinical Biochemistry top 2%
- Hematology top 5%
- Erythropoietin and Anemia Treatment 6
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 5
- Environmental Chemistry top 5%
-
- Renal and related cancers 7
-
- Renal Transplantation Outcomes and Treatments 3
-
- Ferroptosis and cancer prognosis 3
-
- Phagocytosis and Immune Regulation 3
- Immune cells in cancer 3
-
- Urological Disorders and Treatments 3
- Co-authors
- Masayuki YamamotoNorio SuzukiSadayoshi ItoMasahiro NezuIkuo HiranoShun YamazakiLei YuL. Ebony Boulware
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Investigation (2 papers)Nature Communications (1 paper)
- Partner nations
- United StatesJapanCanada
In The Last Decade
Tomokazu Souma
39 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 114
- Nephrology 330
- Clinical Biochemistry 231
- Hematology 317
- Cancer Research 311
- Environmental Chemistry 161
Countries citing papers authored by Tomokazu Souma
This map shows the geographic impact of Tomokazu Souma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomokazu Souma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomokazu Souma more than expected).
Fields of papers citing papers by Tomokazu Souma
This network shows the impact of papers produced by Tomokazu Souma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomokazu Souma. The network helps show where Tomokazu Souma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tomokazu Souma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 7 | |
| 4 | 2022 | 5 | |
| 5 | 2022 | 42 | |
| 6 | 2021 | 18 | |
| 7 | 2021 | 105 | |
| 8 | 2020 | 27 | |
| 9 | 2020 | 134 | |
| 10 | 2019 | 24 | |
| 11 | 2019 | 39 | |
| 12 | 2019 | 9 | |
| 13 | 2018 | 182 | |
| 14 | 2018 | 31 | |
| 15 | 2018 | 71 | |
| 16 | 2017 | 2 | |
| 17 | 2017 | 17 | |
| 18 | 2015 | 129 | |
| 19 | 2013 | 21 | |
| 20 | 2011 | 28 |
About Tomokazu Souma
Tomokazu Souma is a scholar working on Nephrology, Transplantation and Hematology, having authored 40 papers that have together received 2.1k indexed citations. Recurring topics across this work include Renal and related cancers (7 papers), Erythropoietin and Anemia Treatment (6 papers), Cancer, Hypoxia, and Metabolism (5 papers), Renal Transplantation Outcomes and Treatments (3 papers), Ferroptosis and cancer prognosis (3 papers), Phagocytosis and Immune Regulation (3 papers), Urological Disorders and Treatments (3 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Nephrology (330 citations), Clinical Biochemistry (231 citations) and Hematology (317 citations). Tomokazu Souma has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Masayuki Yamamoto, Norio Suzuki, Sadayoshi Ito, Masahiro Nezu, Ikuo Hirano, Shun Yamazaki, Lei Yu, L. Ebony Boulware, John W. Stanifer and Xinlu Zhao. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.